ERG and deep vein thrombosis: Interestingly, acute treatment with a red blood cells-targeted TM was able to restore the levels of TAT, an early biomarker of coagulopathy and thrombosis, showing that loss of TM expression is in part responsible for the prothrombotic phenotype observed in ERG-deficient mice.